New genetic evidence suggests that targeting GIPR and GLP1R can help reduce harmful drinking patterns while improving liver and metabolic health and open the door to...
Almost half Type 2 diabetic patient Two-thirds, which do not stop the GLP-1 receptor agonist within a year, have an adverse event that affects weight loss,...
See how stable blood count setpoints are reshaping decades of risk assessment and disease prediction, unlocking the future of personalized diagnostics. study: Hematological setpoints are stable...
Diabetes is an increasingly prevalent disease, currently affecting more than 500 million adults worldwide. There is still no cure for type 1 or type 2 diabetes,...
A new study conducted at the Columbia University Mailman School of Public Health and the Mount Sinai School of Medicine shows a link between prediabetes in...
A randomized clinical trial was conducted in Chinese adults with early stage type 2 diabetes to determine whether intermittent fasting (IFF) was effective in controlling blood...
Recent Comments